Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds

被引:273
|
作者
Lauer, G
Sollberg, S
Cole, M
Flamme, I
Stürzebecher, J
Mann, K
Krieg, T
Eming, SA
机构
[1] Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany
[2] Ctr Mol Med, Cologne, Germany
[3] Univ Jena, Ctr Vasc Biol & Med, Erfurt, Germany
[4] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
plasmin; serine proteases; VEGF; wound healing;
D O I
10.1046/j.1523-1747.2000.00036.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Degradation of angiogenic mediators might be an underlying cause of chronic wounds. To test this hypothesis, we evaluated the expression and integrity of vascular endothelial growth factor, a potent angiogenic mediator, and its receptors, Flt-1 and KDR, in chronic venous leg ulcerations. Immunohisto- chemical, in situ hybridization, and semiquantitative reverse transcriptase polymerase chain reaction analyses all indicate that expression of vascular endothelial growth factor is elevated in ulcerative tissue, with vascular endothelial growth factor mRNA being especially pronounced in the hyperplastic epithelium of the wound margin. Flt-1 and KDR protein and mRNA were detected in the papillary vessels in close vicinity to the lesional epithelium of chronic wounds. Although increased expression of vascular endothelial growth factor protein was detected in the epidermis, the intensity of this staining was weak compared with the epidermal staining in psoriatic lesions and compared with the strong vascular endothelial growth factor mRNA signal in chronic wounds and psoriasis. To analyze whether this apparent decrease in immunoreactivity could be the result of degradation of vascular endothelial growth factor by proteolytic activities from the wound environment, we examined the stability of recombinant vascular endothelial growth factor in wound fluid from chronic leg ulcers. As demonstrated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, incubation of rVEGF(165) with chronic, but not acute, wound fluid resulted in rapid proteolytic degradation of rVEGF(165). Protease inhibitor studies indicate that serine proteases, such as plasmin, are involved in this degradation. Together, our data show that, although vascular endothelial growth factor expression is elevated in chronic wounds, increased proteolytic activity in this environment results in its degradation, which may contribute to an impaired wound healing response.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [41] Immunohistochemical Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor in Canine Cutaneous Fibrosarcomas
    Al-Dissi, A. N.
    Haines, D. M.
    Singh, B.
    Kidney, B. A.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2009, 141 (04) : 229 - 236
  • [42] Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema
    Kasahara, Y
    Tuder, RM
    Cool, CD
    Lynch, DA
    Flores, SC
    Voelkel, NF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (03) : 737 - 744
  • [43] Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia
    Mints, Miriam
    Hultenby, Kjell
    Zetterberg, Eva
    Blomgren, Bo
    Falconer, Christian
    Rogers, Rick
    Palmblad, Jan
    FERTILITY AND STERILITY, 2007, 88 (03) : 691 - 697
  • [44] Vascular endothelial growth factor vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma
    Shimoda, K
    Mori, M
    Shibuta, K
    Banner, BF
    Barnard, GF
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 14 (02) : 353 - 359
  • [45] INCREASED EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN KIDNEY AND BLADDER CARCINOMAS
    BROWN, LF
    BERSE, B
    JACKMAN, RW
    TOGNAZZI, K
    MANSEAU, EJ
    DVORAK, HF
    SENGER, DR
    AMERICAN JOURNAL OF PATHOLOGY, 1993, 143 (05): : 1255 - 1262
  • [46] Vascular endothelial growth factor in chronic subdural haematomas
    Shono, T
    Inamura, T
    Morioka, T
    Matsumoto, K
    Suzuki, SO
    Ikezaki, K
    Iwaki, T
    Fukui, M
    JOURNAL OF CLINICAL NEUROSCIENCE, 2001, 8 (05) : 411 - 415
  • [47] Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer
    Cvetkovic, D
    Movsas, B
    Dicker, AP
    Hanlon, AL
    Greenberg, RE
    Chapman, JD
    Hanks, GE
    Tricoli, JV
    UROLOGY, 2001, 57 (04) : 821 - 825
  • [48] Increased expression of vascular endothelial growth factor in skin biopsies of patients with amyotrophic lateral sclerosis
    Ono, S
    Yamazaki, T
    Irie, T
    Shiraishi, H
    Wakayama, K
    Suzuki, M
    Shimizu, N
    ANNALS OF NEUROLOGY, 2004, 56 : S21 - S22
  • [49] Increased expression of vascular endothelial growth factor in neo-vascularized canine brain tissue
    Yu, Chi-Ho
    Yhee, Ji-Young
    Kim, Jong-Hyuk
    Im, Keum-Soon
    Kim, Na-Hyun
    Kwon, So-Young
    Hur, Tai-Young
    Sur, Jung-Hyang
    CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2012, 76 (01): : 62 - 68
  • [50] Increased expression of vascular endothelial growth factor (VEGF) mRNA in the kidneys and heart of hypertensive rats
    Gu, JW
    Fortepiani, LA
    Adair, TH
    Wang, J
    Stockton, A
    Li, XR
    HYPERTENSION, 2002, 40 (03) : 438 - 438